Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Venus Concept, a leader in medical aesthetic technology, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. Management's presentation will be available on-demand starting September 13 at 7:00 a.m. Eastern Time. Additionally, virtual investor meetings are scheduled for September 14. The presentation can be accessed via the Company's investor relations website, with a replay available post-conference. Venus Concept operates in over 60 countries, offering a range of minimally and non-invasively aesthetic and hair restoration technologies.
- None.
- None.
TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13th-15th. Management’s presentation will be available on-demand beginning on Monday, September 13th at 7:00 a.m. Eastern Time. Management will participate in virtual investor meetings on Tuesday, September 14th throughout the day.
An audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/. An archive of the webcast will be available for replay following the conference.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 20 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.
FAQ
When is Venus Concept presenting at the H.C. Wainwright Conference?
How can I access Venus Concept's presentation?
When are the virtual investor meetings for Venus Concept?
What technologies does Venus Concept offer?
In how many countries does Venus Concept operate?
